JPRN-UMIN000004944已完成未知
comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia - comparison of pitavastatin versus EPA in patients with dyslipidemia
niversity of Fukui Faculty of Medical Sciences, Division of cardiovascular Medicine0 个研究点目标入组 70 人开始时间: 2011年1月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1,pregnant, breast feeding, or could be pregnant 2,severe liver diseases 3,severe kidney diseases (eGFR<30 mL/min/1.73m2) 4,history of allergic reaction to Pitavastatin or EPA 5,Physician does not agree to join the trial
研究者
相似试验
已完成
不适用
Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary SyndromeAcute coronary syndromeJPRN-UMIN000002742Department of Cardiology, Tokyo Women's Medical University3,000
已完成
4 期
The effect of pitavastatin on the lipoprotein subfraction profile and lipid metabolismJPRN-jRCT1091220056Tokyo Medical and Dental University100
已完成
不适用
Effects of pitavastatin treatments on the plasma Lgi3 level in the patients with dyslipidemia: A randomized crossover trialKCT0003372Yonsei University Health System, Severance Hospital49
已完成
不适用
Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.Patient with dyslipidemia and with coronary artery calcification.(Agatston score 1-999) (Patient of primary prevention of coronary heart disease)JPRN-UMIN000003171Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine,Dentistry and Pharmaceutical Sciences240
招募中
不适用
Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)Patients with stable coronary artery diseaseJPRN-UMIN000008627Minami-Osaka Hospital100